Table 1 Baseline demographics and angiographic data by reperfusion therapy
Variable | Group 1, n = 47 | Group 2, n = 12 | Group 3, n = 8 | Group 4, n = 6 | Group 5, n = 21 | p |
|---|---|---|---|---|---|---|
(PPCI) | (Thrombolysis) | (Rescue-PCI) | (Late PCI) | (Non-reperfused) | ||
Age (years) | 60.5 ± 12.3 | 59.3 ± 10.6 | 59.5 ± 12.5 | 54.7 ± 12.1 | 65.6 ± 16.2 | 0.37 |
Male sex (n,%) | 42 (89.7) | 11 (91.7) | 8 (100) | 5 (83.3) | 16 (76.2) | 0.21 |
Current smoking (n,%) | 23 (48.9) | 6 (50) | 3 (37.5) | 1 (16.7) | 9 (42.9) | 0.64 |
Diabetes (n,%) | 2 (4.3) | 1 (0) | 0 (0) | 0 (0) | 6 (28.6) | 0.01 |
Angina (n,%) | 2 (4.3) | 1 (8.3) | 0 (0) | 0 (0) | 5 (23.8) | 0.07 |
TTR (mins) | 150 (120–240) | 210 (75–300) | 285 (211.25-345) | 1113 (810–1342) | n/a | <0.001 |
Peak CK (iU/L) | 875 (415.3-2061) | 1034 (334.5-1384) | 3002 (758–5045.5) | 2633 (1073.3-5852) | 1033 (87.8-2220.3) | 0.88 |
Angiography |  |  |  |  | (n = 15) |  |
LAD IRA (n,%) | 19 (40.4) | 6 (50) | 4 (50) | 6 (100) | 8 (53.3) | 0.10 |
LCX IRA (n,%) | 8 (17.0) | 0 (0) | 1 (12.5) | 0 (0) | 4 (26.7) | 0.10 |
RCA IRA (n,%) | 20 (42.6) | 6 (50) | 3 (37.5) | 0 (0) | 3 (20.0) | 0.10 |
Multi-vessel disease (n,%) | 16 (34) | 4 (33.3) | 1 (12.5) | 0 (0) | 5 (33.3) | 0.38 |
Rentrop Score | 0 (0–1) | 0 (0–0) | 0 (0–0) | 0 (0-) | 0 (0–0) | 0.51 |
Rentrop B (Grd 2–3, n,%) | 6 (13.3) | 0 (0) | 0 (0) | 1 (16.7) | 1 (6.7) | 0.50 |
TIMI flow pre 0-II (n,%) | 43 (95.6) | 6 (83.3) | 8 (100) | 5 (83.3) | 12 (80.0) | 0.27 |
TIMI flow post III (n,%) | 31 (68.9) | 9 (58.3) | 4 (50) | 4 (66.7) | n/a | 0.82 |
GPIIb/IIIa inhibitor use | 18 (41.9) | 0 (0) | 3 (37.5) | 2 (40) | n/a | 0.39 |
Thrombectomy catheter? | 20 (42.6) | 0 (0) | 5 (62.5) | 1 (16.7) | n/a | 0.01 |